NSE: CONCORDBIO | BSE: 543960

Expensive Performer

Download real time

1099.60 -39.20 (-3.44%)

48.87% Fall from 52W High

146.6K NSE+BSE Volume

NSE 27 May, 2026 3:31 PM (IST)

11,503.6

Market Cap

Market Runner Up

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Concord Biotech is on 29 May 2026 for the purpose of Audited Results & Final Dividend See details

Concord Biotech Ltd. share price target and research reports

Name: Latest research reports of Concord Biotech Ltd. authored by Hem Securities and published by - Trendlyne research reports.
Item: Concord Biotech Ltd.
Rating: 5
Author: Hem Securities

Latest analyst research reports with target prices and PDF download for CONCORDBIO, BSE:543960 Concord Biotech Ltd.

Search Inside the pdf :

Concord Biotech Ltd.

04 Aug 2023

1099.60

-3.44%

Concord Biotech Limited

IPO Subscribe: Concord Biotech Ltd.

Hem Securities

Concord Biotech Ltd.'s price crossed below 30Day SMA today

Concord Biotech Ltd.

03 Aug 2023

1099.60

-3.44%

IPO Note- Concord Biotech Limited

IPO Note: Concord Biotech Ltd.

HDFC Securities

Issue Snapshot: Issue Open: Aug 04 Aug 08, 2023 Price Band: Rs. 705 741 (Discount of Rs 70 for all eligible employees) *Issue Size: 20,925,652 eq sh (Entirely Offer for sale including Employee reservation of 10,000 eq sh) Reservation for: QIB upto 50% eq sh Non-Institutional atleast 15% eq sh ((including 1/3rd for applications between Rs.2 lakhs to Rs.10 lakhs)) Retail atleast 35% eq sh Face Value: Rs 1 Book value: Rs 123.31 (March 31, 2023) Bid size: - 20 equity shares and in multiples thereof 100% Book built Issue IPO Note- Concord Biotech Limited

Concord Biotech has lost -28.45% in the last 1 Year

Concord Biotech Ltd.

03 Aug 2023

1099.60

-3.44%

Concord Biotech Ltd. IPO Note

IPO Note: Concord Biotech Ltd.

Ashika Research

Concord Biotech Ltd. is trading below its 30 day SMA of 1117.8